Showing results (51-60 of 155) with videos related to
Sort By:
Pageof 16
Haematologica|January 29, 2016
Prevalence and characteristics of central nervous system involvement by chronic lymphocytic leukemiaPaolo Strati, Joon H Uhm, Timothy J Kaufmann, et al.Journal of Cutaneous Pathology|March 31, 2026
A Rare Case of Cutaneous Crystal-Storing Histiocytosis With Kappa Light Chain Restriction and Unusual BCL6 ExpressionLiangli Wang, Jonathan L Curry, Julia Dai, et al.Blood|July 31, 2013
Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemiaKoichi Takahashi, Naveen Pemmaraju, Paolo Strati, et al.British Journal of Haematology|June 6, 2017
Relationship between co-morbidities at diagnosis, survival and ultimate cause of death in patients with chronic lymphocytic leukaemia (CLL): a prospective cohort studyPaolo Strati, Sameer A Parikh, Kari G Chaffee, et al.Cancers|July 2, 2021
Early Survival Prediction Framework in CD19-Specific CAR-T Cell Immunotherapy Using a Quantitative Systems Pharmacology ModelAnna Mueller-Schoell, Nahum Puebla-Osorio, Robin Michelet, et al.British Journal of Haematology|September 19, 2022
Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphomaFateeha Furqan, Kwang W Ahn, Yue Chen, et al.American Journal of Hematology|November 2, 2012
FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic leukemiaNaval Daver, Paolo Strati, Elias Jabbour, et al.Transplantation and Cellular Therapy|June 13, 2024
Timing of Toxicities and Non-Relapse Mortality Following CAR T Therapy in MyelomaWilliam Wesson, Danai Dima, Nahid Suleman, et al.British Journal of Haematology|July 21, 2022
A phase 2, multicentre, open-label trial (ACE-LY-003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphomaPaolo Strati, Morton Coleman, Rebecca Champion, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 2, 2021
Human herpesvirus 6 myelitis after chimeric antigen receptor T-cell therapyGuy Handley, Fareed Khawaja, Divya S Kondapi, et al.Pageof 16